Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belzutifan in Preoperative Preparation for PPGL
NCT07907341Phase 4Recruiting
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 4 trial of belzutifan in pheochromocytoma, Paraganglioma (PGL). Started Apr 2026; status: recruiting.
02
Drugs
belzutifan
03
Conditions
pheochromocytomaParaganglioma (PGL)
Beyond the preview
Go deeper on NCT07907341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07907341.